Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening.

Diabetologia - 1 Mar 2020

Jacobsen Laura M, Bocchino Laura, Evans-Molina Carmella, DiMeglio Linda, Goland Robin, Wilson Darrell M, Atkinson Mark A, Aye Tandy, Russell William E, Wentworth John M, Boulware David, Geyer Susan, Sosenko Jay M

Abstract excerpt

AIMS/HYPOTHESIS: Young children who develop multiple autoantibodies (mAbs) are at very high risk for type 1 diabetes. We assessed whether a population with mAbs detected by screening is also at very high risk, and how risk varies according to age, type of autoantibodies and metabolic status. METHODS: Type 1 Diabetes TrialNet Pathway to Prevention participants with mAbs (n = 1815; age, 12.35 ± 9.39 years; range,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Autoimmune Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 1

Share to Glucose Tolerance Test

Share to Individuality

Share to Mass Screening

Share to Monitoring, Physiologic

Share to Prediabetic State

Source

Open in PubMed Open full text

Identifiers

PMID: 31768570
DOI: 10.1007/s00125-019-05047-w
PMCID: PMC7229995

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening.PMID 31768570Read ↗

Risk for progression to type 1 diabetes in first-degree relatives under 50 years of age.Semantic proximity Read ↗

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.Semantic proximity Read ↗

Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 DiabetesSemantic proximity Read ↗

Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years.Semantic proximity Read ↗

Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes.Semantic proximity Read ↗

Autoimmune Diabetes From Childhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype.Semantic proximity Read ↗

The absence of islet autoantibodies in clinically diagnosed older-adult onset type 1 diabetes suggests an alternative pathology, advocating for routine testing in this age groupSemantic proximity Read ↗

Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: A systematic review and meta-analysis.Semantic proximity Read ↗

Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.Semantic proximity Read ↗

Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomized trialSemantic proximity Read ↗

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.Semantic proximity Read ↗

Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.